Al momento, questa pagina non è disponibile nella lingua scelta. È possibile visualizzare una traduzione automatica realizzata con Google Translate. Renishaw declina qualsiasi responsabilità relativa alla fornitura di tale servizio e specifica di non avere controllato la traduzione.
È possibile contattarci per richiedere ulteriore assistenza.
RA802 Pharmaceutical Analyser literature
Product note: RA802 Pharmaceutical Analyser
The RA802 Pharmaceutical Analyser is a compact benchtop Raman imaging system that redefines formulation analysis. It is easy to use, yet gives rich chemical information. Designed exclusively for the pharmaceutical industry, the RA802 rapidly obtains detailed information on the distribution of chemical species. With unique LiveTrack™ focus-tracking technology, it can efficiently analyse uneven, curved, or rough surfaces at incredible speeds and without any sample preparation.
Technical note: LiveTrack focus-tracking technology
LiveTrack focus-tracking technology maintains optimum focus for both white light and Raman imaging to give stunning 3D images. It is used in Renishaw’s inVia™ Qontor® confocal Raman microscope, and RA802 and RA816 analysers.[772kB]
Application note: Using Raman spectroscopy to tackle polymorphism, an industry problem
This note looks at incidences of polymorphism in drug development including advantages and challenges. Ultimately this case study examines the trial of SmithKline Beecham (SKB) v Apotex, where Renishaw’s Raman instruments were used by SKB in an attempt to prove infringement of its Paxil® patent by Apotex, a generic competitor.
Application note: New methods for determining content uniformity of formulations
The uniformity of a drug product’s contents is a parameter that requires constant monitoring. It is important from a handling/processing standpoint, and it is of the utmost importance for patient safety to ensure that the correct dose is delivered every time.
Application note: Rapid polymorph identification with the RA802 Pharmaceutical Analyser
The stability, bioavailability and processability of an active pharmaceutical ingredient (API) are key to a candidate molecule’s ability to be developed into a commercially viable product, sometimes referred to its ‘drugability’. Characterising the polymorphism of APIs has become an important consideration in this process.
White paper: Finding fakes – using Raman imaging to identify counterfeit medicines
Identifying counterfeit drugs has become an area of increasing focus for regulatory authorities and also for pharmaceutical companies. Raman spectroscopy is highly specific and can differentiate between materials with similar chemical structures. This specificity makes Raman well-suited to identifying counterfeits which often use similar components to the reference product.
White paper: Methods for deformulating drugs
In this white paper we look at reverse engineering existing drug products using Raman imaging. We show that the Renishaw RA802 Pharmaceutical Analyser can be used to successfully characterise innovator and generic products and facilitate deformulation activities, and can characterise the components, concentrations, particle sizes and distributions of the innovator formulation, allowing generic followers to adjust their processes in order to create equivalent products, or products which are strategically different.